Clinical & Payment Policies
Clinical Policies
Clinical policies are one set of guidelines used to assist in administering health plan benefits, either by prior authorization or payment rules. They include but are not limited to policies relating to evolving medical technologies and procedures, as well as pharmacy policies. Clinical policies help identify whether services are medically necessary based on information found in generally accepted standards of medical practice; peer-reviewed medical literature; government agency/program approval status; evidence-based guidelines and positions of leading national health professional organizations; views of physicians practicing in relevant clinical areas affected by the policy; and other available clinical information.
All policies found in the Western Sky Community Care Clinical Policy Manual apply to Western Sky Community Care members. Policies in the Western Sky Community Care Clinical Policy Manual may have either a Western Sky Community Care or a “Centene” heading. Western Sky Community Care utilizes InterQual® criteria for those medical technologies, procedures or pharmaceutical treatments for which a Western Sky Community Care clinical policy does not exist. InterQual is a nationally recognized evidence-based decision support tool. You may access the InterQual® SmartSheet(s)™ for Adult and Pediatric procedures, durable medical equipment and imaging procedures by logging into the secure provider portal or by calling Western Sky Community Care. In addition, Western Sky Community Care may from time to time delegate utilization management of specific services; in such circumstances, the delegated vendor’s guidelines may also be used to support medical necessity and other coverage determinations. Other non-clinical policies (e.g., payment policies) or contract terms may further determine whether a technology, procedure or treatment that is not addressed in the Clinical Policy Manuals or InterQual®criteria is payable by Western Sky Community Care.
If you have any questions regarding these policies, please contact Member Services and ask to be directed to the Medical Management department.
For Medicare information, please visit our Medicare Prior Authorization website.
POLICY NUMBER | POLICY | EFFECTIVE DATE |
---|---|---|
NM.CP.PPA.09 (PDF) | Ribavirin (Copegus, Moderiba, Rebetol, Ribasphere) | 1/1/2019 |
CP.PHAR.345 (PDF) | Abaloparatide (Tymlos) | 7/1/17 |
CP.PMN.253 (PDF) | Abametapir (Xeglyze) | 12/1/20 |
CP.PHAR.241 (PDF) | Abatacept (Orencia) | 8/1/16 |
CP.PHAR.355 (PDF) | Abemaciclib (Verzenio) | 10/24/17 |
CP.PHAR.84 (PDF) | Abiraterone (Zytiga, Yonsa) | 10/1/11 |
CP.PHAR.230 (PDF) | AbobotulinumtoxinA (Dysport) | 7/1/16 |
CP.PHAR.578 (PDF) | Abrocitinib (Cibinqo) | 6/1/22 |
CP.PHAR.366 (PDF) | Acalabrutinib (Calquence) | 3/1/18 |
CP.PMN.61 (PDF) | ACEI and ARB Duplicate Therapy | 8/1/14 |
CP.PMN.40 (PDF) | Acitretin (Soriatane) | 8/31/10 |
CP.PMN.210 (PDF) | Acyclovir Buccal Tablet (Sitavig) | 9/1/19 |
CP.PHAR.242 (PDF) | Adalimumab (Humira), Adalimumab-afzb (Abrilada), Adalimumab-atto (Amjevita), Adalimumab-adbm (Cyltezo), Adalimumab-bwwd (Hadlima), Adalimumab-fkjp (Hulio), Adalimumab-adaz (Hyrimoz) | 8/1/16 |
CP.PHAR.142 (PDF) | Adefovir (Hepsera) | 8/28/18 |
CP.PHAR.229 (PDF) | Ado-Trastuzumab Emtansine (Kadcyla) | 6/1/16 |
CP.PHAR.468 (PDF) | Aducanumab-avwa (Aduhelm) | 6/1/20 |
CP.PHAR.444 (PDF) | Afamelanotide (Scenesse) | 3/1/20 |
CP.PHAR.298 (PDF) | Afatinib (Gilotrif) | 1/1/17 |
CP.PHAR.184 (PDF) | Aflibercept (Eylea) | 3/1/16 |
CP.PHAR.158 (PDF) | Agalsidase Beta (Fabrazyme) | 2/1/16 |
CP.PMN.191 (PDF) | Age Limit for Topical Tretinoin | 1/29/19 |
CP.PMN.138 (PDF) | Age Limit Override (Codeine, Tramadol, Hydrocodone) | 3/13/18 |
CP.PHAR.369 (PDF) | Alectinib (Alecensa) | 11/16/16 |
CP.PHAR.243 (PDF) | Alemtuzumab (Lemtrada) | 8/1/16 |
CP.PMN.88 (PDF) | Alendronate (Binosto, Fosamax Plus D) | 2/28/18 |
CP.PHAR.160 (PDF) | Alglucosidase Alfa (Lumizyme) | 2/1/16 |
CP.PHAR.124 (PDF) | Alirocumab (Praluent) | 10/1/15 |
CP.PHAR.562 (PDF) | Allogeneic Cultured Keratinocytes and Dermal Fibroblasts in Murine Collagen-dsat (StrataGraft) | 3/1/22 |
CP.PHAR.563 (PDF) | Allogenic Processed Thymus Tissue-agdc (Rethymic) | 3/1/22 |
CP.PMN.153 (PDF) | Alosetron (Lotronex) | 11/16/16 |
CP.PHAR.430 (PDF) | Alpelisib (Piqray, Vijoice) | 9/1/19 |
CP.PHAR.94 (PDF) | Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin-C, Zemaira) | 3/1/12 |
CP.PMN.89 (PDF) | Amantadine ER (Gocovri, Osmolex ER) | 10/10/17 |
CP.PHAR.190 (PDF) | Ambrisentan (Letairis) | 3/1/16 |
CP.PHAR.411 (PDF) | Amifampridine (Firdapse) | 1/22/19 |
CP.PHAR.401 (PDF) | Amikacin (Arikayce) | 11/13/18 |
CP.PMN.236 (PDF) | Amisulpride (Barhemsys) | 9/1/20 |
CP.PHAR.544 (PDF) | Amivantamab-vmjw (Rybrevant) | 9/1/21 |
CP.PMN.176 (PDF) | Amlodipine/Atorvastatin (Caduet) | 12/1/18 |
CP.PHAR.244 (PDF) | Anakinra (Kineret) | 8/1/16 |
CP.PHAR.551 (PDF) | Anifrolumab-fnia (Saphnelo) | 12/1/21 |
CP.PHAR.217 (PDF) | Anti-Inhibitor Coagulant Complex, Human (Feiba) | 5/1/16 |
CP.PHAR.564 (PDF) | Antithrombin III (ATryn, Thrombate III) | 3/1/22 |
CP.PHAR.506 (PDF) | Antithymocyte Globulin (Atgam, Thymoglobulin) | 12/1/20 |
CP.PHAR.376 (PDF) | Apalutamide (Erleada) | 6/1/18 |
CP.PHAR.488 (PDF) | Apomorphine (Apokyn, Kynmobi) | 9/1/20 |
CP.PHAR.245 (PDF) | Apremilast (Otezla) | 8/1/16 |
CP.PMN.19 (PDF) | Aprepitant (Emend, Cinvanti), Fosaprepitant (Emend for injection) | 11/30/16 |
CP.PHAR.510 (PDF) | Arimoclomol (Brand Name) | 12/1/20 |
CP.PMN.35 (PDF) | Armodafinil (Nuvigil) | 8/1/09 |
CP.PHAR.565 (PDF) | Asciminib (Scemblix) | 3/1/22 |
CP.PMN.15 (PDF) | Asenapine (Saphris, Secuado) | 12/1/14 |
CP.PHAR.328 (PDF) | Asfotase Alfa (Strensiq) | 3/1/17 |
CP.PMN.20 (PDF) | Aspirin/Dipyridamole (Aggrenox) | 9/1/06 |
CP.PHAR.235 (PDF) | Atezolizumab (Tecentriq) | 6/1/16 |
CP.PHAR.566 (PDF) | Atogepant (Qulipta) | 3/1/22 |
CP.PHAR.515 (PDF) | Avacopan (Tavneos) | 3/1/21 |
CP.PHAR.521 (PDF) | Avalglucosidase Alfa-ngpt (Nexviazyme) | 3/1/21 |
CP.PHAR.454 (PDF) | Avapritinib (Ayvakit) | 3/1/20 |
CP.PHAR.130 (PDF) | Avatrombopag (Doptelet) | 7/17/18 |
CP.PHAR.333 (PDF) | Avelumab (Bavencio) | 5/1/17 |
CP.PHAR.362 (PDF) | Axicabtagene Ciloleucel (Yescarta) | 10/31/17 |
CP.PHAR.100 (PDF) | Axitinib (Inlyta) | 5/1/12 |
CP.PHAR.387 (PDF) | Azacitidine (Onureg, Vidaza) | 8/28/18 |
CP.PHAR.209 (PDF) | Aztreonam (Cayston) | 5/1/16 |
CP.PHAR.149 (PDF) | Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax) | 11/9/17 |
CP.PMN.185 (PDF) | Baloxavir Marboxil (Xofluza) | 10/30/18 |
CP.PHAR.560 (PDF) | Bardoxolone Methyl (RTA 402) | 12/1/21 |
CP.PHAR.135 (PDF) | Baricitinib (Olumiant) | 7/24/18 |
CP.PMN.212 (PDF) | Bedaquiline (Sirturo) | 12/1/19 |
CP.PHAR.469 (PDF) | Belantamab Mafodotin-blmf (Blenrep) | 6/1/20 |
CP.PHAR.201 (PDF) | Belatacept (Nulojix) | 11/9/17 |
CP.PHAR.88 (PDF) | Belimumab (Benlysta) | 10/1/11 |
CP.PHAR.311 (PDF) | Belinostat (Beleodaq) | 2/1/17 |
CP.PHAR.552(PDF) | Belumosudil (Rezurock) | 12/1/21 |
CP.PHAR.553 (PDF) | Belzutifan (Welireg) | 12/1/21 |
CP.PMN.237 (PDF) | Bempedoic Acid (Nexletol), Bempedoic Acid/Ezetimibe (Nexlizet) | 9/1/20 |
CP.PHAR.307 (PDF) | Bendamustine (Belrapzo, Bendeka, Treanda) | 2/1/17 |
CP.PHAR.373 (PDF) | Benralizumab (Fasenra) | 1/16/18 |
CP.PMN.90 (PDF) | Benznidazole | 10/17/17 |
NM.CP.PPA.16 (PDF) | Benzodiazepines and Opioids | 4/1/2019 |
CP.PMN.202 (PDF) | Benzyl Alcohol (Ulesfia) | 9/1/19 |
CP.PHAR.592 (PDF) | Beremagene Geperpavec (Vyjuvek) | 12/1/22 |
CP.PHAR.485 (PDF) | Berotralstat (Orladeyo) | 6/1/20 |
CP.PHAR.143 (PDF) | Betaine (Cystadane) | 8/28/18 |
CP.PMN.182 (PDF) | Betamethasone Dipropionate Spray (Sernivo) | 12/1/18 |
CP.PHAR.545 (PDF) | Betibeglogene Autotemcel (Zynteglo) | 9/1/21 |
CP.PHAR.93 (PDF) | Bevacizumab (Alymsys, Avastin, Mvasi, Vegzelma, Zirabev) | 10/31/11 |
CP.PHAR.75 (PDF) | Bexarotene (Targretin Capsules, Gel) | 9/1/11 |
CP.PHAR.300 (PDF) | Bezlotoxumab (Zinplava) | 11/16/16 |
CP.PHAR.486 (PDF) | Bimatoprost Implant (Durysta) | 6/1/20 |
CP.PHAR.50 (PDF) | Binimetinib (Mektovi) | 7/24/18 |
CP.PHAR.312 (PDF) | Blinatumomab (Blincyto) | 2/1/17 |
CP.PMN.151 (PDF) | Blood Glucose Test Strip Quantity Limit - Not Receiving Insulin | 9/1/07 |
CP.PHAR.410 (PDF) | Bortezomib (Velcade) | 12/11/18 |
CP.PHAR.191 (PDF) | Bosentan (Tracleer) | 3/1/16 |
CP.PHAR.105 (PDF) | Bosutinib (Bosulif) | 10/1/12 |
CP.PMN.22 (PDF) | Brand Name Override | 9/1/06 |
CP.PHAR.303 (PDF) | Brentuximab Vedotin (Adcetris) | 2/1/17 |
CP.PHAR.417 (PDF) | Brexanolone (Zulresso) | 4/16/19 |
CP.PHAR.472 (PDF) | Brexucabtagene Autoleucel (Tecartus) | 6/1/20 |
CP.PHAR.342 (PDF) | Brigatinib (Alunbrig) | 7/17/17 |
CP.PMN.192 (PDF) | Brimonidine Tartrate (Mirvaso) | 11/15/16 |
CP.PHAR.375 (PDF) | Brodalumab (Siliq) | 6/1/18 |
CP.PHAR.445 (PDF) | Brolucizumab-dbll (Beovu) | 2/29/20 |
CP.PHAR.572 (PDF) | Budesonide (Tarpeyo) | 3/1/22 |
CP.PHAR.589 (PDF) | Bulevirtide (Hepcludex) | 9/1/22 |
CP.PHAR.11 (PDF) | Burosumab-twza (Crysvita) | 5/8/18 |
CP.PHAR.202 (PDF) | C1 Esterase Inhibitors (Berinert, Cinryze, Haegarda, Ruconest) | 3/1/16 |
CP.PHAR.316 (PDF) | Cabazitaxel (Jevtana) | 2/1/17 |
CP.PHAR.111 (PDF) | Cabozantinib (Cabometyx, Cometriq) | 6/1/13 |
CP.PMN.76 (PDF) | Calcifediol (Rayaldee) | 11/1/16 |
CP.PMN.181 (PDF) | Calcipotriene/Betamethasone Dipropionate Foam (Enstilar) | 12/1/18 |
CP.PHAR.246 (PDF) | Canakinumab (Ilaris) | 8/1/16 |
CP.PMN.164 (PDF) | Cannabidiol (Epidiolex) | 7/17/18 |
CP.PHAR.416 (PDF) | Caplacizumab-yhdp (Cablivi) | 3/12/19 |
CP.PHAR.494 (PDF) | Capmatinib (Tabrecta) | 9/1/20 |
CP.PMN.137 (PDF) | Carbamazepine ER (Equetro) | 3/13/18 |
CP.PHAR.546 (PDF) | Carbetocin | 9/1/21 |
CP.PMN.238 (PDF) | Carbidopa/Levodopa ER Capsules (Rytary), Enteral Suspension (Duopa), IR Tablets (Dhivy) | 9/1/20 |
CP.PHAR.309 (PDF) | Carfilzomib (Kyprolis) | 2/1/17 |
CP.PHAR.206 (PDF) | Carglumic Acid (Carbaglu) | 5/1/16 |
CP.PMN.91 (PDF) | Cariprazine (Vraylar) | 11/16/16 |
CP.PHAR.470 (PDF) | Casimersen (Amondys 45) | 6/1/20 |
CP.PHAR.520 (PDF) | Casirivimab and Imdevimab (REGEN-COV) | 12/22/20 |
CP.PMN.122 (PDF) | Celecoxib (Celebrex, Elyxyb) | 1/1/07 |
CP.PHAR.397 (PDF) | Cemiplimab-rwlc (Libtayo) | 10/16/18 |
CP.PMN.186 (PDF) | Cenegermin-bkbj (Oxervate) | 10/9/18 |
CP.PMN.231 (PDF) | Cenobamate (Xcopri) | 3/1/20 |
CP.PHAR.349 (PDF) | Ceritinib (Zykadia) | 7/1/17 |
CP.PHAR.338 (PDF) | Cerliponase Alfa (Brineura) | 7/1/17 |
CP.PHAR.247(PDF) | Certolizumab (Cimzia) | 8/1/16 |
CP.PHAR.317 (PDF) | Cetuximab (Erbitux) | 2/1/17 |
CP.PMN.239 (PDF) | Chenodiol (Chenodal) | 9/1/20 |
CP.PHAR.554 (PDF) | Chlorambucil (Leukeran) | 12/1/21 |
CP.PHAR.388 (PDF) | Chloramphenicol Sodium Succinate | 12/1/18 |
CP.PHAR.390 (PDF) | Cholic Acid (Cholbam) | 12/1/18 |
CP.PMN.24 (PDF) | Ciclopirox (Penlac) | 9/1/07 |
CP.PHAR.533 (PDF) | Ciltacabtagene Autoleucel (Carvykti) | 5/7/21 |
CP.PHAR.61 (PDF) | Cinacalcet (Sensipar) | 5/1/11 |
CP.PHAR.567 (PDF) | Cipaglucosidase Alfa/Miglustat (AT-GAA) | 3/1/22 |
CP.PMN.248 (PDF) | Ciprofloxacin/Dexamethasone (Ciprodex) | 12/1/20 |
CP.PMN.249 (PDF) | Ciprofloxacin/Fluocinolone (Otovel) | 12/1/20 |
CP.PHAR.422 (PDF) | Cladribine (Mavenclad) | 9/1/19 |
CP.PMN.257 (PDF) | Clascoterone (Winlevi) | 2/28/21 |
CP.PHAR.260 (PDF) | Clinical Policy: Rituximab (Rituxan), Rituximab-arrx (Riabni), Rituximab-pvvr (Ruxience), Rituximab-abbs (Truxima), Rituximab-Hyaluronidase (Rituxan Hycela) | 7/1/16 |
CP.PMN.54 (PDF) | Clobazam (Onfi, Sympazan) | 11/1/12 |
CP.PMN.197 (PDF) | Clomipramine (Anafranil) | 3/13/18 |
CP.PMN.12 (PDF) | Clozapine Orally Disintegrating Tablet | 8/1/15 |
CP.PMN.92 (PDF) | CNS Stimulants | 3/1/18 |
CP.PHAR.380 (PDF) | Cobimetinib (Cotellic) | 11/16/16 |
CP.PMN.123 (PDF) | Colchicine (Colcrys) | 5/1/11 |
CP.PMN.250 (PDF) | Colesevelam (Welchol) | 12/1/20 |
CP.PHAR.82 (PDF) | Collagenase Clostridium Histolyticum (Xiaflex) | 10/1/11 |
CP.PMN.280 (PDF) | Compounded Medications | 9/1/22 |
CP.PMN.258 (PDF) | Conjugated Estrogens/Bazedoxifene (Duavee) | 3/1/21 |
CP.PMN.214 (PDF) | Continuous Glucose Monitors | 12/1/19 |
CP.PHAR.357 (PDF) | Copanlisib (Aliqopa) | 10/17/17 |
CP.PHAR.385 (PDF) | Corticosteroids for Ophthalmic Injection (Iluvien, Ozurdex, Retisert, Xipere, Yutiq) | 5/29/18 |
CP.PHAR.203 (PDF) | Cosyntropin (Cortrosyn) | 4/1/16 |
CP.PMN.110 (PDF) | Crisaborole (Eucrisa) | 2/21/17 |
CP.PHAR.449 (PDF) | Crizanlizumab-tmca (Adakveo) | 3/1/20 |
CP.PHAR.90 (PDF) | Crizotinib (Xalkori) | 11/1/11 |
CP.PMN.48 (PDF) | Cyclosporine (Cequa, Restasis, Verkazia) | 5/1/12 |
CP.PMN.130 (PDF) | Cysteamine Ophthalmic (Cystaran, Cystadrops) | 8/1/17 |
CP.PHAR.155 (PDF) | Cysteamine oral (Cystagon, Procysbi) | 2/1/16 |
CP.PHAR.277 (PDF) | Cytomegalovirus Immune Globulin (CytoGam) | 9/1/18 |
CP.PMN.49 (PDF) | Dabigatran (Pradaxa) | 5/1/12 |
CP.PHAR.239 (PDF) | Dabrafenib (Tafinlar) | 11/16/16 |
CP.PHAR.399 (PDF) | Dacomitinib (Vizimpro) | 10/16/18 |
CP.PHAR.248 (PDF) | Dalfampridine (Ampyra) | 8/1/16 |
CP.PHAR.225 (PDF) | Dalteparin (Fragmin) | 5/1/16 |
CP.PHAR.351 (PDF) | Daptomycin (Cubicin, Cubicin RF) | 11/30/17 |
CP.PHAR.310 (PDF) | Daratumumab (Darzalex), Daratumumab/Hyaluronidase-fihj (Darzalex Faspro) | 7/1/17 |
CP.PHAR.236 (PDF) | Darbepoetin Alfa (Aranesp) | 6/1/16 |
CP.PHAR.435 (PDF) | Darolutamide (Nubeqa) | 12/1/19 |
CP.PHAR.72 (PDF) | Dasatinib (Sprycel) | 6/1/12 |
CP.PHAR.352 (PDF) | Daunorubicin/Cytarabine (Vyxeos) | 12/1/17 |
CP.PHAR.479 (PDF) | Decitabine/Cedazuridine (Inqovi) | 6/1/20 |
CP.PHAR.145 (PDF) | Deferasirox (Exjade, Jadenu) | 11/1/15 |
CP.PHAR.147 (PDF) | Deferiprone (Ferriprox) | 11/1/15 |
CP.PHAR.146 (PDF) | Deferoxamine (Desferal) | 11/1/15 |
CP.PHAR.331 (PDF) | Deflazacort (Emflaza) | 3/1/17 |
CP.PHAR.170 (PDF) | Degarelix Acetate (Firmagon) | 11/9/17 |
CP.PMN.115 (PDF) | Delafloxacin (Baxdela) | 11/9/17 |
CP.PHAR.593 (PDF) | Delandistrogene Moxeparvovec (SRP-9001) | 12/1/22 |
CP.PHAR.58 (PDF) | Denosumab (Prolia, Xgeva) | 3/1/11 |
CP.PHAR.214 (PDF) | Desmopressin Acetate (DDAVP, Stimate, Nocdurna, Noctiva) | 5/1/16 |
CP.PHAR.341 (PDF) | Deutetrabenazine (Austedo) | 6/13/17 |
CP.PHAR.418 (PDF) | Dexrazoxane (Totect) | 3/19/19 |
CP.PMN.93 (PDF) | Dextromethorphan-Quinidine (Nuedexta) | 3/1/18 |
CP.PMN.284 (PDF) | Dextromethorphan/Bupropion (Auvelity) | 12/1/22 |
CP.PMN.216 (PDF) | Diazepam Nasal Spray (Valtoco) | 12/1/19 |
CP.PMN.261 (PDF) | Dichlorphenamide (Keveyis) | 3/1/21 |
CP.PMN.274 (PDF) | Diclofenac (Pennsaid) | 3/1/22 |
CP.PHAR.249 (PDF) | Dimethyl Fumarate (Tecfidera), Diroximel Fumarate (Vumerity), Monomethyl Fumarate (Bafiertam) | 8/1/16 |
CP.PMN.03 (PDF) | Dipeptidyl Peptidase-4 (DPP-4) Inhibitors | 9/19/18 |
CP.PMN.141 (PDF) | Dolasetron (Anzemet) | 9/1/06 |
CP.PHAR.594 (PDF) | Donanemab (LY3002813) | 12/1/22 |
CP.PHAR.569 (PDF) | Donislecel (Lantidra) | 3/1/22 |
CP.PHAR.212 (PDF) | Dornase Alfa (Pulmozyme) | 5/1/16 |
CP.PHAR.540 (PDF) | Dostarlimab-gxly (Jemperli) | 9/1/21 |
CP.PMN.175 (PDF) | Doxepin (Silenor) | 12/1/18 |
CP.PMN.79 (PDF) | Doxycycline Hyclate (Acticlate, Doryx), Doxycycline (Oracea) | 5/1/17 |
CP.PMN.159 (PDF) | Dronabinol (Marinol, Syndros) | 11/16/16 |
CP.PMN.17 (PDF) | Droxidopa (Northera) | 11/9/17 |
CP.PHAR.336 (PDF) | Dupilumab (Dupixent) | 5/1/17 |
CP.PHAR.339 (PDF) | Durvalumab (Imfinzi) | 7/1/17 |
CP.PMN.128 (PDF) | Dutasteride (Avodart), Dutasteride/Tamsulosin (Jalyn) | 5/1/16 |
CP.PHAR.400 (PDF) | Duvelisib (Copiktra) | 10/16/18 |
CP.PMN.234 (PDF) | Early and Periodic Screening, Diagnostic, and Treatment Benefit for Pediatric Members | 6/1/20 |
CP.PHAR.177 (PDF) | Ecallantide (Kalbitor) | 3/1/16 |
CP.PHAR.97 (PDF) | Eculizumab (Soliris) | 3/1/12 |
CP.PHAR.343 (PDF) | Edaravone (Radicava, Radivaca ORS) | 7/1/17 |
CP.PMN.227 (PDF) | Edoxaban (Savaysa) | 1/1/20 |
CP.PHAR.555 (PDF) | Efgartigimod Alfa-fcab (Vyvgart) | 12/1/21 |
CP.PMN.25 (PDF) | Efinaconazole (Jublia) | 8/1/16 |
CP.PHAR.595 (PDF) | Eladocagene Exuparvovec (Upstaza) | 12/1/22 |
CP.PHAR.136 (PDF) | Elagolix (Orilissa), Elagolix/Estradiol/Norethinedrone (Oriahnn) | 8/28/18 |
CP.PHAR.419 (PDF) | Elapegademase-lvlr (Revcovi) | 4/23/19 |
CP.PHAR.440 (PDF) | Elexacaftor/Ivacaftor/Tezacaftor; Ivacaftor (Trikafta) | 12/1/19 |
CP.PHAR.153 (PDF) | Eliglustat (Cerdelga) | 2/1/16 |
CP.PHAR.556 (PDF) | Elivaldogene Autotemcel (Skysona) | 12/1/21 |
CP.PHAR.162 (PDF) | Elosulfase Alfa (Vimizim) | 2/1/16 |
CP.PHAR.308 (PDF) | Elotuzumab (Empliciti) | 2/1/17 |
CP.PHAR.180 (PDF) | Eltrombopag (Promacta) | 3/1/16 |
CP.PMN.170 (PDF) | Eluxadoline (Viberzi) | 12/1/18 |
CP.PHAR.402 (PDF) | Emapalumab-lzsg (Gamifant) | 12/11/18 |
CP.PHAR.370 (PDF) | Emicizumab-kxwh (Hemlibra) | 3/1/18 |
CP.PHAR.363 (PDF) | Enasidenib (Idhifa) | 9/5/17 |
CP.PHAR.127 (PDF) | Encorafenib (Braftovi) | 7/24/18 |
CP.PHAR.455 (PDF) | Enfortumab Vedotin-ejfv (Padcev) | 3/1/20 |
CP.PHAR.41 (PDF) | Enfuvirtide (Fuzeon) | 6/1/10 |
CP.PHAR.224 (PDF) | Enoxaparin (Lovenox) | 5/1/16 |
CP.PHAR.441 (PDF) | Entrectinib (Rozlytrek) | 12/1/19 |
CP.PHAR.106 (PDF) | Enzalutamide (Xtandi) | 10/1/12 |
CP.PMN.144 (PDF) | Epinephrine (Auvi-Q, EpiPen, EpiPen Jr) Quantity Limit Override | 8/1/16 |
CP.PHAR.237 (PDF) | Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) | 6/1/16 |
CP.PHAR.192 (PDF) | Epoprostenol (Flolan, Veletri) | 3/1/16 |
CP.PHAR.489 (PDF) | Eptinezumab-jjmr (Vyepti) | 9/1/20 |
CP.PHAR.423 (PDF) | Erdafitinib (Balversa) | 9/1/19 |
CP.PHAR.128 (PDF) | Erenumab-aooe (Aimovig) | 7/10/18 |
CP.PHAR.318 (PDF) | Eribulin Mesylate (Halaven) | 3/1/17 |
CP.PHAR.74 (PDF) | Erlotinib (Tarceva) | 9/1/11 |
CP.PHAR.301 (PDF) | Erwinia Asparaginase (Erwinaze, Rylaze) | 2/1/17 |
CP.PMN.199 (PDF) | (PDF)Esketamine (Spravato) | 3/12/19 |
CP.PMN.263 (PDF) | Estradiol Vaginal Ring (Femring) | 1/1/22 |
CP.PHAR.250 (PDF) | Etanercept (Enbrel) | 8/1/16 |
CP.PHAR.379 (PDF) | Etelcalcetide (Parsabiv) | 3/20/18 |
CP.PHAR.288 (PDF) | Eteplirsen (Exondys 51) | 12/1/16 |
CP.PHAR.580 (PDF) | Etranacogene Dezaparvovec (AMT-061) | 6/1/22 |
CP.PHAR.63 (PDF) | Everolimus (Afinitor, Afinitor Disperz, Zortress) | 6/1/11 |
CP.PHAR.511 (PDF) | Evinacumab-dgnb (Evkeeza) | 12/1/20 |
CP.PHAR.123 (PDF) | Evolocumab (Repatha) | 10/1/15 |
CP.PHAR.218 (PDF) | Factor IX (Human, Recombinant) | 5/1/16 |
CP.PHAR.219 (PDF) | Factor IX Complex, Human (Profilnine) | 5/1/16 |
CP.PHAR.220 (PDF) | Factor VIIa, Recombinant (NovoSeven RT, SevenFact) | 5/1/16 |
CP.PHAR.215 (PDF) | Factor VIII (Human, Recombinant) | 5/1/16 |
CP.PHAR.216 (PDF) | Factor VIII/von Willebrand Factor Complex (Human – Alphanate, Humate-P, Wilate); von Willebrand Factor (Recombinant – Vonvendi) | 5/1/16 |
CP.PHAR.222 (PDF) | Factor XIII A-Subunit, Recombinant (Tretten) | 5/1/16 |
CP.PHAR.221 (PDF) | Factor XIII, Human (Corifact) | 5/1/16 |
CP.PHAR.456 (PDF) | Fam-Trastuzumab Deruxtecan-nxki (Enhertu) | 3/1/20 |
CP.PHAR.581 (PDF) | Faricimab-svoa (Vabysmo) | 6/1/22 |
CP.PMN.57 (PDF) | Febuxostat (Uloric) | 8/1/13 |
CP.PHAR.442 (PDF) | Fedratinib (Inrebic) | 12/1/19 |
CP.PMN.246 (PDF) | Fenfluramine (Fintepla) | 9/1/20 |
CP.PMN.127 (PDF) | Fentanyl IR (Abstral, Actiq, Fentora, Lazanda, Subsys) | 6/1/15 |
CP.PHAR.234 (PDF) | Ferric Carboxymaltose (Injectafer) | 6/1/16 |
CP.PHAR.480 (PDF) | Ferric Derisomaltose (Monoferric) | 6/1/20 |
CP.PHAR.166 (PDF) | Ferric Gluconate (Ferrlecit) | 3/1/16 |
CP.PMN.213 (PDF) | Ferric Maltol (Accrufer) | 12/1/19 |
CP.PHAR.165 (PDF) | Ferumoxytol (Feraheme) | 3/1/16 |
CP.PHAR.526 (PDF) | Fibrinogen Concentrate [Human] (Fibryga, RiaSTAP) | 6/1/21 |
CP.PHAR.297 (PDF) | Filgrastim (Neupogen), Filgrastim-sndz (Zarxio), Tbo-filgrastim (Granix), Filgrastim-aafi (Nivestym), Filgrastim-ayow (Releuko) | 12/1/16 |
CP.PMN.266 (PDF) | Finerenone (Kerendia) | 12/1/21 |
CP.PHAR.251 (PDF) | Fingolimod (Gilenya, Tascenso ODT) | 8/1/16 |
CP.PMN.165 (PDF) | Fluorouracil Cream (Tolak) | 12/1/18 |
CP.PMN.95 (PDF) | Fluticasone Propionate (Xhance) | 10/24/17 |
CP.PHAR.226 (PDF) | Fondaparinux (Arixtra) | 5/1/16 |
CP.PHAR.471 (PDF) | Fosdenopterin (Nulibry) | 6/1/20 |
CP.PHAR.24 (PDF) | Fostamatinib (Tavalisse) | 6/5/18 |
CP.PHAR.516 (PDF) | Fostemsavir (Rukobia) | 3/1/21 |
CP.PHAR.403 (PDF) | Fremanezumab-vfrm (Ajovy) | 10/30/18 |
CP.PHAR.424 (PDF) | Fulvestrant (Faslodex Injection) | 9/1/19 |
CP.PMN.240 (PDF) | Gabapentin ER (Gralise, Horizant) | 9/1/20 |
CP.PHAR.404 (PDF) | Galcanezumab-gnlm (Emgality) | 11/13/18 |
CP.PHAR.161 (PDF) | Galsulfase (Naglazyme) | 2/1/16 |
CP.PMN.278 (PDF) | Ganaxolone (Ztalmy) | 6/1/22 |
CP.PHAR.68 (PDF) | Gefitinib (Iressa) | 11/16/16 |
CP.PHAR.358 (PDF) | Gemtuzumab Ozogamicin (Mylotarg) | 10/3/17 |
CP.PHAR.412 (PDF) | Gilteritinib (Xospata) | 1/15/19 |
CP.PHAR.457 (PDF) | Givosiran (Givlaari) | 3/1/20 |
CP.PHAR.413 (PDF) | Glasdegib (Daurismo) | 1/8/19 |
CP.PHAR.252 (PDF) | Glatiramer Acetate (Copaxone, Glatopa) | 8/1/16 |
NM.CP.PPA.01 (PDF) | glecaprevir-pibrentasvir (Mavyret) | |
CP.PMN.183 (PDF) | Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists | 9/19/18 |
CP.PHAR.207 (PDF) | Glycerol Phenylbutyrate (Ravicti) | 4/30/16 |
CP.PMN.177 (PDF) | Glycopyrronium (Qbrexza) | 8/13/18 |
CP.PHAR.253 (PDF) | Golimumab (Simponi, Simponi Aria) | 7/1/16 |
CP.PHAR.453 (PDF) | Golodirsen (Vyondys 53) | 3/1/20 |
CP.PHAR.171 (PDF) | Goserelin Acetate (Zoladex) | 11/9/17 |
CP.PMN.74 (PDF) | Granisetron (Sancuso, Sustol) | 11/1/16 |
CP.PHAR.364 (PDF) | Guselkumab (Tremfya) | 8/29/17 |
CP.PMN.180 (PDF) | Halobetasol Propionate (Bryhali, Lexette, Ultravate) | 12/1/18 |
CP.PMN.208 (PDF) | Halobetasol Propionate/Tazarotene (Duobrii) | 9/1/19 |
CP.PHAR.181 (PDF) | Hemin (Panhematin) | 2/1/16 |
CP.PHAR.172 (PDF) | Histrelin Acetate (Vantas, Supprelin LA) | 11/9/17 |
NM.CP.PPA.11 (PDF) | HIV Medications | |
CP.PMN.111 (PDF) | House Dust Mite Allergen Extract (Odactra) | 8/31/17 |
CP.PHAR.517 (PDF) | Human Growth Hormone (Somapacitan, Somatropin) | 3/1/21 |
CP.PHAR.05 (PDF) | Hyaluronate Derivatives | 10/1/08 |
CP.PMN.193 (PDF) | Hydroxyurea (Siklos) | 2/19/19 |
CP.PHAR.378 (PDF) | Ibalizumab-uiyk (Trogarzo) | 4/17/18 |
CP.PHAR.189 (PDF) | Ibandronate Injection (Boniva) | 11/15/17 |
CP.PMN.96 (PDF) | Ibandronate Oral (Boniva) | 3/1/18 |
CP.PHAR.126 (PDF) | Ibrutinib (Imbruvica) | 10/1/15 |
CP.PMN.120 (PDF) | Ibuprofen/Famotidine (Duexis) | 6/1/18 |
CP.PHAR.178 (PDF) | Icatibant (Firazyr) | 3/1/16 |
CP.PMN.187 (PDF) | Icosapent Ethyl (Vascepa) | 11/20/18 |
CP.PHAR.481 (PDF) | Idecabtagene Vicleucel (Abecma) | 6/1/20 |
CP.PHAR.133 (PDF) | Idelalisib (Zydelig) | 12/1/18 |
CP.PHAR.156 (PDF) | Idursulfase (Elaprase) | 2/1/16 |
CP.PMN.32 (PDF) | Iloperidone (Fanapt) | 12/1/14 |
CP.PHAR.193 (PDF) | Iloprost (Ventavis) | 3/1/16 |
CP.PHAR.65 (PDF) | Imatinib (Gleevec) | 6/1/11 |
CP.PHAR.154 (PDF) | Imiglucerase (Cerezyme) | 2/1/16 |
CP.PHAR.103 (PDF) | Immune Globulins | 8/1/12 |
CP.PHAR.28 (PDF) | Immunization Coverage | 10/1/08 |
CP.PHAR.568 (PDF) | Inclisiran (Leqvio) | 3/1/22 |
CP.PHAR.231 (PDF) | IncobotulinumtoxinA (Xeomin) | 7/1/16 |
CP.PHAR.458 (PDF) | Inebilizumab-cdon (Uplizna) | 3/1/20 |
CP.PHAR.131 (PDF) | Infertility and Fertility Preservation | 11/16/16 |
CP.PHAR.547 (PDF) | Infigratinib (Truseltiq) | 9/1/21 |
CP.PHAR.254 (PDF) | Infliximab (Remicade), Infliximab-axxq (Avsola), Infliximab-dyyb (Inflectra), and Infliximab-abda (Renflexis) | 7/1/16 |
CP.PMN.259 (PDF) | Inhaled Agents for Asthma and COPD | 3/1/21 |
CP.PHAR.405 (PDF) | Inotersen (Tegsedi) | 11/20/18 |
CP.PHAR.359 (PDF) | Inotuzumab Ozogamicin (Besponsa) | 9/26/17 |
CP.PHAR.534 (PDF) | Insulin Delivery Systems (V-Go, Omnipod, InPen) | 6/1/21 |
CP.PHAR.255 (PDF) | Interferon Beta-1a (Avonex, Rebif) | 8/1/16 |
CP.PHAR.256 (PDF) | Interferon Beta-1b (Betaseron, Extavia) | 8/1/16 |
CP.PHAR.52 (PDF) | Interferon Gamma- 1b (Actimmune) | 6/1/10 |
CP.PHAR.459 (PDF) | Iobenguane I-131 (Azedra) | 3/1/20 |
CP.PHAR.319 (PDF) | Ipilimumab (Yervoy) | 4/17/18 |
CP.PHAR.304 (PDF) | Irinotecan Liposome (Onivyde) | 2/1/17 |
CP.PHAR.167 (PDF) | Iron Sucrose (Venofer) | 3/1/16 |
CP.PHAR.482 (PDF) | Isatuximab-irfc (Sarclisa) | 6/1/20 |
CP.PMN.154 (PDF) | Isavuconazonium (Cresemba) | 11/16/16 |
CP.PMN.143 (PDF) | Isotretinoin (Absorica, Absorica LD, Amnesteem, Claravis, Myorisan, Zenatane) | 12/1/14 |
CP.PMN.217 (PDF) | Istradefylline (Nourianz) | 3/1/20 |
CP.PMN.124 (PDF) | Itraconazole (Sporanox, Tolsura) | 11/1/06 |
CP.PMN.70 (PDF) | Ivabradine (Corlanor) | 11/1/15 |
CP.PHAR.210 (PDF) | Ivacaftor (Kalydeco) | 5/1/16 |
CP.PMN.269 (PDF) | Ivermectin (Stromectol, Sklice) | 12/1/21 |
CP.PHAR.137 (PDF) | Ivosidenib (Tibsovo) | 8/21/18 |
CP.PHAR.302 (PDF) | Ixazomib (Ninlaro) | 2/1/17 |
CP.PHAR.257 (PDF) | Ixekizumab (Taltz) | 8/1/16 |
CP.PMN.282 (PDF) | Ketorolac Nasal Spray (Sprix) | 12/1/22 |
CP.PMN.116 (PDF) | L-glutamine (Endari) | 11/9/17 |
CP.PMN.155 (PDF) | Lacosamide (Vimpat) | 12/1/14 |
CP.PHAR.396 (PDF) | Lanadelumab-fylo (Takhzyro) | 9/25/18 |
CP.PHAR.391 (PDF) | Lanreotide (Somatuline Depot) | 8/14/18 |
CP.PHAR.79 (PDF) | Lapatinib (Tykerb) | 11/9/17 |
CP.PHAR.152 (PDF) | Laronidase (Aldurazyme) | 2/1/16 |
CP.PHAR.414 (PDF) | Larotrectinib (Vitrakvi) | 1/15/18 |
CP.PMN.218 (PDF) | Lasmiditan (Reyvow) | 3/1/20 |
CP.PMN.108 (PDF) | Latanoprostene Bunod (Vyzulta) | 3/1/18 |
CP.PHAR.596 (PDF) | Lecanemab (BAN2401) | 12/1/22 |
NM.CP.PPA.04 (PDF) | ledipasvir-sofosbuvir (Harvoni) | |
CP.PMN.219 (PDF) | Lefamulin (Xenleta) | 3/1/20 |
CP.PHAR.71 (PDF) | Lenalidomide (Revlimid) | 7/1/11 |
CP.PHAR.597 (PDF) | Leniolisib (CDZ173) | 12/1/22 |
CP.PHAR.138 (PDF) | Lenvatinib (Lenvima) | 12/1/18 |
CP.PHAR.367 (PDF) | Letermovir (Prevymis) | 3/1/18 |
CP.PHAR.393 (PDF) | Leucovorin Injection | 12/1/18 |
CP.PHAR.173 (PDF) | Leuprolide Acetate (Eligard, Fensolvi, Lupaneta Pack, Lupron Depot, Lupron Depot-Ped), Leuprolide mesylate (Camcevi) | 11/9/17 |
CP.PMN.267 (PDF) | Levodopa Inhalation Powder (Inbrija) | 12/1/21 |
CP.PMN.275 (PDF) | Levoketoconazole (Recorlev) | 6/1/22 |
CP.PHAR.151 (PDF) | Levoleucovorin (Fusilev, Khapzory) | 11/9/17 |
CP.PMN.08 (PDF) | Lidocaine Transdermal (Lidoderm, ZTlido) | 9/1/06 |
CP.PHAR.598 (PDF) | Lifileucel (LN-144) | 12/1/22 |
CP.PMN.73 (PDF) | Lifitegrast (Xiidra) | 11/9/17 |
CP.PMN.71 (PDF) | Linaclotide (Linzess) | 11/1/15 |
CP.PMN.09 (PDF) | Lindane Shampoo | 11/1/06 |
CP.PMN.27 (PDF) | Linezolid (Zyvox) | 9/1/16 |
CP.PHAR.483 (PDF) | Lisocabtagene Maraleucel (Breyanzi) | 6/1/20 |
CP.PMN.152 (PDF) | Lofexidine (Lucemyra) | 8/1/18 |
CP.PHAR.283 (PDF) | Lomitapide (Juxtapid) | 10/1/16 |
CP.PHAR.507 (PDF) | Lomustine (Gleostine) | 12/1/20 |
CP.PHAR.499 (PDF) | Lonafarnib (Zokinvy) | 9/1/20 |
CP.PHAR.539 (PDF) | Loncastuximab Tesirine-lpyl (Zynlonta) | 9/1/21 |
CP.PMN.279 (PDF) | Long-term Antibiotic Treatment for Tick-borne Diseases | 6/2/22 |
CP.PHAR.406 (PDF) | Lorlatinib (Lorbrena) | 12/11/18 |
CP.PMN.260 (PDF) | Loteprednol etabonate (Eysuvis) | 3/1/21 |
CP.PMN.142 (PDF) | Lubiprostone (Amitiza) | 12/1/14 |
CP.PMN.166 (PDF) | Luliconazole Cream (Luzu) | 8/28/18 |
CP.PHAR.213 (PDF) | Lumacaftor/Ivacaftor (Orkambi) | 5/1/16 |
CP.PHAR.473 (PDF) | Lumasiran (Oxlumo) | 6/1/20 |
CP.PMN.232 (PDF) | Lumateperone (Caplyta) | 3/1/20 |
CP.PMN.50 (PDF) | Lurasidone (Latuda) | 12/1/14 |
CP.PHAR.500 (PDF) | Lurbinectedin (Zepzelca) | 9/1/20 |
CP.PHAR.450 (PDF) | Luspatercept-aamt (Reblozyl) | 3/1/20 |
CP.PHAR.407 (PDF) | Lusutrombopag (Mulpleta) | 9/18/18 |
CP.PHAR.384 (PDF) | Lutetium Lu 177 Dotatate (Lutathera) | 5/22/18 |
CP.PHAR.582 (PDF) | Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) | 6/1/22 |
CP.PHAR.194 (PDF) | Macitentan (Opsumit) | 3/1/16 |
CP.PHAR.518 (PDF) | Mannitol (Bronchitol) | 3/1/21 |
CP.PHAR.543 (PDF) | Maralixibat (Livmarli) | 9/1/21 |
CP.PHAR.522 (PDF) | Margetuximab-cmkb (Margenza) | 3/1/21 |
CP.PMN.271 (PDF) | Maribavir (Livtencity) | 3/1/22 |
CP.PMN.272 (PDF) | Mavacamten (Camzyos) | 3/1/22 |
CP.PMN.136 (PDF) | Mecamylamine (Vecamyl) | 5/1/17 |
CP.PHAR.150 (PDF) | Mecasermin (Increlex) | 3/1/11 |
CP.PHAR.381 (PDF) | Mechlorethamine Gel (Valchlor) | 11/16/16 |
CP.PMN.179 (PDF) | Megestrol Acetate (Megace ES) | 12/1/18 |
CP.PHAR.535 (PDF) | Melphalan flufenamide (Pepaxto) | 6/1/21 |
CP.PHAR.200 (PDF) | Mepolizumab (Nucala) | 4/1/16 |
CP.PHAR.447 (PDF) | Mercaptopurine (Purixan) | 3/1/20 |
CP.PMN.72 (PDF) | Metformin ER (Fortamet, Glumetza) | 10/31/15 |
CP.PMN.161 (PDF) | Methadone Hydrochloride | 12/1/18 |
CP.PHAR.134 (PDF) | Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex) | 12/1/18 |
CP.PHAR.238 (PDF) | Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) | 6/1/16 |
CP.PMN.169 (PDF) | Methylnaltrexone Bromide (Relistor) | 12/1/18 |
CP.PMN.252 (PDF) | Metoclopramide (Gimoti) | 12/1/20 |
CP.PHAR.425 (PDF) | Metreleptin (Myalept) | 9/1/19 |
CP.PMN.211 (PDF) | Midazolam (Nayzilam) | 9/1/19 |
CP.PHAR.344 (PDF) | Midostaurin (Rydapt) | 6/1/17 |
CP.PHAR.101 (PDF) | Mifepristone (Korlym) | 5/1/12 |
CP.PHAR.394 (PDF) | Migalastat (Galafold) | 9/11/18 |
CP.PHAR.164 (PDF) | Miglustat (Zavesca) | 2/1/16 |
CP.PMN.125 (PDF) | Milnacipran (Savella) | 8/1/12 |
CP.PMN.80 (PDF) | Minocycline ER (Solodyn, Ximino, Minolira), Microspheres (Arestin), Foam (Zilxi) | 4/30/17 |
CP.PMN.242 (PDF) | Minocycline Micronized Foam (Amzeeq) | 9/1/20 |
CP.PHAR.558 (PDF) | Mitapivat (Pyrukynd) | 12/1/21 |
CP.PHAR.495 (PDF) | Mitomycin for Pyelocalyceal Solution (Jelmyto) | 9/1/20 |
CP.PHAR.258 (PDF) | Mitoxantrone | 8/1/16 |
CP.PHAR.559 (PDF) | Mobocertinib (Exkivity) | 12/1/21 |
CP.PMN.39 (PDF) | Modafinil (Provigil) | 5/1/08 |
CP.PHAR.139 (PDF) | Mogamulizumab-kpkc (Poteligeo) | 9/4/18 |
CP.PHAR.448 (PDF) | Mometasone Furoate (Sinuva) | 3/1/20 |
CP.PHAR.398 (PDF) | Moxetumomab pasudotox-tdfk (Lumoxiti) | 10/16/18 |
CP.PHAR.461 (PDF) | Nadofaragene Firadenovec (Instiladrin) | 3/1/20 |
CP.PHAR.174 (PDF) | Nafarelin Acetate (Synarel) | 11/9/17 |
CP.PMN.112 (PDF) | Naldemedine (Symproic) | 5/1/17 |
CP.PMN.171 (PDF) | Naloxegol (Movantik) | 12/1/18 |
CP.PHAR.96 (PDF) | Naltrexone (Vivitrol) | 3/1/12 |
CP.PMN.117 (PDF) | Naproxen/Esomeprazole (Vimovo) | 6/1/18 |
CP.PHAR.527 (PDF) | Narsoplimab (OMS721) | 6/1/21 |
CP.PHAR.259 (PDF) | Natalizumab (Tysabri) | 7/1/16 |
CP.PHAR.523 (PDF) | Naxitamab-gqgk (Danyelza) | 3/1/21 |
CP.PHAR.320 (PDF) | Necitumumab (Portrazza) | 3/1/17 |
CP.PMN.167 (PDF) | Neomycin/Fluocinolone Cream (Neo-Synalar) | 8/28/18 |
CP.PHAR.365 (PDF) | Neratinib (Nerlynx) | 9/5/17 |
CP.PMN.118 (PDF) | Netarsudil (Rhopressa), Netarsudil/Latanoprost (Rocklatan) | 2/13/18 |
CP.PMN.158 (PDF) | Netupitant and Palonosetron (Akynzeo), Fosnetupitant and Palonosetron (Akynzeo IV) | 9/1/06 |
CP.PMN.256 (PDF) | Nifurtimox (Lampit) | 12/1/20 |
CP.PHAR.76 (PDF) | Nilotinib (Tasigna) | 9/1/11 |
CP.PHAR.285 (PDF) | Nintedanib (Ofev) | 10/1/16 |
CP.PHAR.408 (PDF) | Niraparib (Zejula) | 5/9/17 |
CP.PHAR.132 (PDF) | Nitisinone (Nityr, Orfadin) | 8/28/18 |
CP.PHAR.121 (PDF) | Nivolumab (Opdivo) | 7/1/15 |
CP.PHAR.588 (PDF) | Nivolumab and Relatlimab-rmbw (Opdualag) | 9/1/22 |
CP.PMN.255 (PDF) | No Coverage Criteria, Recent Label Changes Pending Clinical Policy Update | 12/1/20 |
CP.PMN.04 (PDF) | Non-Calcium Phosphate Binders | 11/15/17 |
CP.PMN.215 (PDF) | Non-Preferred Blood Glucose Monitors/Test Strips | 12/1/19 |
CP.PHAR.327 (PDF) | Nusinersen (Spinraza) | 11/28/17 |
CP.PHAR.287 (PDF) | Obeticholic Acid (Ocaliva) | 11/1/16 |
CP.PHAR.305 (PDF) | Obinutuzumab (Gazyva) | 2/1/17 |
CP.PHAR.335 (PDF) | Ocrelizumab (Ocrevus) | 4/1/17 |
CP.PHAR.40 (PDF) | Octreotide Acetate (Sandostatin, Sandostatin LAR Depot, Bynfezia, Mycapssa) | 3/1/10 |
CP.PHAR.528 (PDF) | Odevixibat (Bylvay) | 6/1/21 |
CP.PHAR.306 (PDF) | Ofatumumab (Arzerra, Kesimpta) | 2/1/17 |
CP.PMN.53 (PDF) | Off-Label Use | 9/12/17 |
CP.PMN.265 (PDF) | Olanzapine/Samidorphan (Lybalvi) | 9/1/21 |
CP.PHAR.360 (PDF) | Olaparib (Lynparza) | 10/3/17 |
CP.PHAR.326 (PDF) | Olaratumab (Lartruvo) | 3/1/17 |
CP.PHAR.586 (PDF) | Olipudase Alfa-rpcp (Xenpozyme) | 6/2/22 |
CP.PHAR.108 (PDF) | Omacetaxine (Synribo) | 4/1/13 |
CP.PMN.188 (PDF) | Omadacycline (Nuzyra) | 11/20/18 |
CP.PHAR.01 (PDF) | Omalizumab (Xolair) | 10/1/08 |
CP.PHAR.590 (PDF) | Omaveloxolone (RTA-408) | 9/1/22 |
CP.PHAR.585 (PDF) | Omburtamab (Omblastys) | 12/1/22 |
CP.PMN.52 (PDF) | Omega-3-Acid Ethyl Esters (Lovaza) | 8/1/12 |
CP.PHAR.232 (PDF) | OnabotulinumtoxinA (Botox) | 7/1/16 |
CP.PHAR.421 (PDF) | Onasemnogene Abeparvovec (Zolgensma) | 6/7/19 |
CP.PMN.45 (PDF) | Ondansetron (Zuplenz) | 9/1/06 |
CP.PHAR.536 (PDF) | Ophthalmic Riboflavin (Photrexa, Photrexa Viscous) | 6/1/21 |
CP.PMN.245 (PDF) | Opicapone (Ongentys) | 9/1/20 |
CP.PMN.97 (PDF) | Opioid Analgesics* | 2/1/11 |
CP.PHAR.487 (PDF) | Osilodrostat (Isturisa) | 9/1/20 |
CP.PHAR.294 (PDF) | Osimertinib (Tagrisso) | 12/1/16 |
CP.PMN.168 (PDF) | Ospemifene (Osphena) | 8/28/18 |
CP.PMN.198 (PDF) | Overactive Bladder Agents | 5/1/16 |
CP.PMN.86 (PDF) | Oxymetazoline (Rhofade, Upneeq) | 11/15/16 |
CP.PHAR.462 (PDF) | Ozanimod (Zeposia) | 3/1/20 |
CP.PMN.119 (PDF) | Ozenoxacin (Xepi) | 1/30/18 |
CP.PHAR.176 (PDF) | Paclitaxel, Protein-Bound (Abraxane) | 7/1/15 |
CP.PHAR.583 (PDF) | Pacritinib (Vonjo) | 6/1/22 |
CP.PHAR.125 (PDF) | Palbociclib (Ibrance) | 10/1/15 |
NM.CP.PHAR.10 (PDF) | palivizumab (Synagis) | |
CP.PHAR.548 (PDF) | Palovarotene | 9/1/21 |
CP.PMN.226 (PDF) | Pancrelipase (Creon, Pancreaze, Pertzye, Viokace, Zenpep) | 1/1/20 |
CP.PHAR.321 (PDF) | Panitumumab (Vectibix) | 3/1/17 |
CP.PHAR.382 (PDF) | Panobinostat (Farydak) | 11/16/16 |
CP.PHAR.282 (PDF) | Parathyroid Hormone (Natpara) | 11/16/16 |
CP.PHAR.270 (PDF) | Paricalcitol Injection (Zemplar) | 8/1/16 |
CP.PHAR.332 (PDF) | Pasireotide (Signifor, Signifor LAR) | 3/1/17 |
CP.PMN.205 (PDF) | Patiromer (Veltassa) | 9/1/19 |
CP.PHAR.395 (PDF) | Patisiran (Onpattro) | 9/11/18 |
CP.PHAR.81 (PDF) | Pazopanib (Votrient) | 10/1/11 |
CP.PMN.220 (PDF) | Peanut Allergen Powder-dnfp (Palforzia) | 3/1/20 |
CP.PHAR.185 (PDF) | Pegaptanib (Macugen) | 3/1/16 |
CP.PHAR.353 (PDF) | Pegaspargase (Oncaspar), Calaspargase Pegol-mknl (Asparlas) | 9/5/17 |
CP.PHAR.524 (PDF) | Pegcetacoplan (Empaveli, APL-2) | 3/1/21 |
CP.PHAR.296 (PDF) | Pegfilgrastim (Neulasta, Neulasta Onpro), Pegfilgrastim-jmdb (Fulphila), Pegfilgrastim-pbbk (Fylnetra), Pegfilgrastim-apgf (Nyvepria), Eflapegrastim-xnst (Rolvedon), Pegfilgrastim-fpgk (Stimufend), Pegfilgrastim-cbqv (Udenyca), Pegfilgrastim-bmez (Ziexten | 12/1/16 |
CP.PHAR.89 (PDF) | Peginterferon Alfa-2a,b (Pegasys, PegIntron) | 10/1/11 |
CP.PHAR.271 (PDF) | Peginterferon Beta-1a (Plegridy) | 8/1/16 |
CP.PHAR.115 (PDF) | Pegloticase (Krystexxa) | 6/1/13 |
CP.PHAR.512 (PDF) | Pegunigalsidase Alfa (PRX-102) | 12/1/20 |
CP.PHAR.140 (PDF) | Pegvaliase-pqpz (Palynziq) | 7/31/18 |
CP.PHAR.389 (PDF) | Pegvisomant (Somavert) | 12/1/18 |
CP.PHAR.587 (PDF) | Pegzilarginase (AEB1102) | 9/1/22 |
CP.PHAR.322 (PDF) | Pembrolizumab (Keytruda) | 3/1/17 |
CP.PHAR.368 (PDF) | Pemetrexed (Alimta, Pemfexy) | 10/31/17 |
CP.PHAR.496 (PDF) | Pemigatinib (Pemazyre) | 9/1/20 |
CP.PMN.276 (PDF) | Pentosan Polysulfate Sodium (Elmiron) | 6/1/22 |
CP.PMN.156 (PDF) | Perampanel (Fycompa) | 11/16/16 |
CP.PMN.174 (PDF) | Perindopril/Amlodipine (Prestalia) | 12/1/18 |
CP.PHAR.227 (PDF) | Pertuzumab (Perjeta) | 6/1/16 |
CP.PHAR.501 (PDF) | Pertuzumab/Trastuzumab/Hyaluronidase-zzxf (Phesgo) | 9/1/20 |
CP.PHAR.436 (PDF) | Pexidartinib (Turalio) | 12/1/19 |
CP.PMN.270 (PDF) | Pilocarpine (Vuity) | 12/1/21 |
CP.PMN.140 (PDF) | Pimavanserin (Nuplazid) | 11/16/16 |
CP.PHAR.286 (PDF) | Pirfenidone (Esbriet) | 10/1/16 |
CP.PMN.221 (PDF) | Pitolisant (Wakix) | 3/1/20 |
CP.PHAR.513 (PDF) | Plasminogen, Human-tvmh (Ryplazim) | 6/3/21 |
CP.PMN.87 (PDF) | Plecanatide (Trulance) | 2/1/17 |
CP.PHAR.323 (PDF) | Plerixafor (Mozobil) | 3/1/17 |
CP.PHAR.433 (PDF) | Polatuzumab Vedotin-piiq (Polivy) | 9/1/19 |
CP.PHAR.116 (PDF) | Pomalidomide (Pomalyst) | 7/1/13 |
CP.PHAR.112 (PDF) | Ponatinib (Iclusig) | 6/1/13 |
CP.PHAR.537 (PDF) | Ponesimod (Ponvory) | 6/1/21 |
CP.PHAR.313 (PDF) | Pralatrexate (Folotyn) | 2/1/17 |
CP.PHAR.514 (PDF) | Pralsetinib (Gavreto) | 12/1/20 |
CP.PMN.129 (PDF) | Pramlintide (Symlin) | 6/1/18 |
CP.PMN.99 (PDF) | Prasterone (Intrarosa) | 12/20/16 |
CP.PMN.33 (PDF) | Pregabalin (Lyrica, Lyrica CR) | 1/1/07 |
CP.PMN.222 (PDF) | Pretomanid | 3/1/20 |
CP.PMN.243 (PDF) | Progesterone (Crinone, Endometrin, Milprosa) | 9/1/20 |
CP.PMN.58 (PDF) | Propranolol HCl Oral Solution (Hemangeol) | 5/1/14 |
CP.PHAR.330 (PDF) | Protein C Concentrate, Human (Ceprotin) | 3/1/17 |
CP.PMN.194 (PDF) | Prucalopride (Motegrity) | 1/29/19 |
NM.CP.PPA.15 (PDF) | Psychotropic (behavioral health) Medications | |
NM.CP.PPA.18 (PDF) | Psychotropic Medication Use Parameters for Children | |
CP.PMN.44 (PDF) | Pyrimethamine (Daraprim) | 11/1/15 |
CP.PMN.59 (PDF) | Quantity Limit Override and Dose Optimization | 11/9/17 |
CP.PMN.262 (PDF) | Quinine Sulfate (Qualaquin) | 6/1/21 |
CP.PMN.173 (PDF) | Ramelteon (Rozerem) | 12/1/18 |
CP.PHAR.119 (PDF) | Ramucirumab (Cyramza) | 5/1/15 |
CP.PHAR.186 (PDF) | Ranibizumab (Byooviz, Cimerli, Lucentis, Susvimo) | 4/1/16 |
CP.PMN.34 (PDF) | Ranolazine (Ranexa, Aspruzyo Sprinkle) | 8/1/09 |
CP.PHAR.415 (PDF) | Ravulizumab-cwvz (Ultomiris) | 2/19/19 |
CP.PHAR.107 (PDF) | Regorafenib (Stivarga) | 12/1/12 |
CP.PHAR.529 (PDF) | Relugolix (Orgovyx), Relugolix/Estradiol/Norethinedrone (Myfembree) | 6/1/21 |
CP.PHAR.474 (PDF) | Remestemcel-L (Ryoncil) | 6/1/20 |
CP.PHAR.168 (PDF) | Repository Corticotropin Injection (H.P. Acthar Gel, Purified Cortrophin Gel) | 3/1/16 |
CP.PMN.16 (PDF) | Request for Medically Necessary Drug Not on the PDL | 11/9/17 |
CP.PHAR.223 (PDF) | Reslizumab (Cinqair) | 5/1/16 |
CP.PHAR.141 (PDF) | Ribavirin (Rebetol, Ribasphere) | 11/16/16 |
CP.PHAR.334 (PDF) | Ribociclib (Kisqali), Ribociclib/Letrozole (Kisqali Femara) | 5/1/17 |
CP.PMN.223 (PDF) | Rifabutin (Mycobutin) | 3/1/20 |
CP.PMN.196 (PDF) | Rifamycin (Aemcolo) | 1/8/19 |
CP.PMN.05 (PDF) | Rifapentine (Priftin) | 2/1/16 |
CP.PMN.47 (PDF) | Rifaximin (Xifaxan) | 11/1/11 |
CP.PHAR.266 (PDF) | Rilonacept (Arcalyst) | 11/16/16 |
CP.PHAR.233 (PDF) | RimabotulinumtoxinB (Myobloc) | 7/1/16 |
CP.PHAR.490 (PDF) | Rimegepant (Nurtec ODT) | 9/1/20 |
CP.PHAR.195 (PDF) | Riociguat (Adempas) | 3/1/16 |
CP.PHAR.502 (PDF) | Ripretinib (Qinlock) | 9/1/20 |
CP.PHAR.426 (PDF) | Risankizumab-rzaa (Skyrizi) | 6/3/19 |
CP.PHAR.477 (PDF) | Risdiplam (Evrysdi) | 8/6/20 |
CP.PMN.100 (PDF) | Risedronate (Actonel, Atelvia) | 3/1/18 |
CP.PMN.247 (PDF) | Rivaroxaban (Xarelto) | 9/1/20 |
CP.PMN.101 (PDF) | Rivastigmine (Exelon) | 3/1/17 |
CP.PMN.46 (PDF) | Roflumilast (Daliresp, Zoryve) | 11/30/11 |
CP.PMN.102 (PDF) | Rolapitant (Varubi) | 2/1/17 |
CP.PHAR.314 (PDF) | Romidepsin (Istodax) | 1/1/17 |
CP.PHAR.179 (PDF) | Romiplostim (Nplate) | 3/1/16 |
CP.PHAR.428 (PDF) | Romosozumab-aqqg (Evenity) | 9/1/19 |
CP.PHAR.570 (PDF) | Ropeginterferon Alfa-2b-njft (BESREMi) | 3/1/22 |
CP.PHAR.599 (PDF) | RP-L201 | 12/1/22 |
CP.PHAR.350 (PDF) | Rucaparib (Rubraca) | 9/1/17 |
CP.PMN.157 (PDF) | Rufinamide (Banzel) | 12/1/14 |
CP.PHAR.98 (PDF) | Ruxolitinib (Jakafi, Opzelura) | 3/1/12 |
CP.PHAR.475 (PDF) | Sacituzumab Govitecan-hziy (Trodelvy) | 6/1/20 |
CP.PMN.113 (PDF) | Safinamide (Xadago) | 7/1/17 |
CP.PHAR.43 (PDF) | Sapropterin Dihydrochloride (Kuvan) | 2/1/10 |
CP.PMN.189 (PDF) | Sarecycline (Seysara) | 11/13/18 |
CP.PHAR.295 (PDF) | Sargramostim (Leukine) | 12/1/16 |
CP.PHAR.346 (PDF) | Sarilumab (Kevzara) | 7/18/17 |
CP.PHAR.463 (PDF) | Satralizumab-mwge (Enspryng) | 3/1/20 |
CP.PHAR.159 (PDF) | Sebelipase Alfa (Kanuma) | 2/1/16 |
CP.PMN.103 (PDF) | Secnidazole (Solosec) | 10/24/17 |
CP.PHAR.261 (PDF) | Secukinumab (Cosentyx) | 8/1/16 |
CP.PHAR.196 (PDF) | Selexipag (Uptravi) | 3/1/16 |
CP.PHAR.431 (PDF) | Selinexor (Xpovio) | 9/1/19 |
CP.PHAR.478 (PDF) | Selpercatinib (Retevmo) | 6/1/20 |
CP.PHAR.464 (PDF) | Selumetinib (Koselugo) | 3/1/20 |
CP.PHAR.491 (PDF) | Setmelanotide (Imcivree) | 9/1/20 |
CP.PMN.83 (PDF) | Short Ragweed Pollen Allergen Extract (Ragwitek) | 8/31/17 |
CP.PHAR.197 (PDF) | Sildenafil (Revatio) | 3/1/16 |
CP.PHAR.329 (PDF) | Siltuximab (Sylvant) | 3/1/17 |
CP.PHAR.427 (PDF) | Siponimod (Mayzent) | 9/1/19 |
CP.PHAR.120 (PDF) | Sipuleucel-T (Provenge) | 6/1/15 |
CP.PHAR.574 (PDF) | Sirolimus Protein-Bound Particles (Fyarro), Topical Gel (Hyftor) | 3/1/22 |
CP.PMN.42 (PDF) | Sodium Oxybate (Xyrem) and Calcium, Magnesium, Potassium, and Sodium Oxybate (Xywav) | 5/1/11 |
CP.PHAR.208 (PDF) | Sodium Phenylbutyrate (Buphenyl, Pheburane) | 5/1/16 |
CP.PHAR.584 (PDF) | Sodium Phenylbutyrate/Taurursodiol (Relyvrio) | 6/1/22 |
CP.PMN.163 (PDF) | Sodium Zirconium Cyclosilicate (Lokelma) | 7/24/18 |
CP.PMN.14 (PDF) | Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors | 9/19/18 |
NM.CP.PPA.06 (PDF) | sofosbuvir (Sovaldi) | |
NM.CP.PPA.03 (PDF) | sofosbuvir-velpatasvir (Epclusa) | |
NM.CP.PPA.05 (PDF) | sofosbuvir-velpatasvir-voxilaprevir (Vosevi) | |
CP.PMN.209 (PDF) | Solriamfetol (Sunosi) | 9/1/19 |
CP.PHAR.272 (PDF) | Sonidegib (Odomzo) | 5/1/12 |
CP.PHAR.69 (PDF) | Sorafenib (Nexavar) | 7/1/11 |
CP.PHAR.549 (PDF) | Sotorasib (Lumakras) | 9/1/21 |
CP.PHAR.541 (PDF) | Sotrovimab (VIR-7831) | 9/1/21 |
CP.PMN.60 (PDF) | SSRI/SNRI Duplicate Therapy | 5/31/14 |
CP.PMN.184 (PDF) | Stiripentol (Diacomit) | 9/25/18 |
CP.PHAR.73 (PDF) | Sunitinib (Sutent) | 9/1/11 |
CP.PHAR.503 (PDF) | Sutimlimab-jome (Enjaymo) | 2/3/22 |
CP.PMN.109 (PDF) | Suvorexant (Belsomra) | 2/1/17 |
CP.PMN.85 (PDF) | Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract (Oralair) | 8/31/17 |
CP.PHAR.198 (PDF) | Tadalafil (Adcirca, Alyq, Tadliq) | 3/1/16 |
CP.PMN.132 (PDF) | Tadalafil BPH - ED (Cialis) | 6/1/18 |
CP.PHAR.432 (PDF) | Tafamidis (Vyndaqel, Vyndamax) | 9/1/19 |
CP.PHAR.508 (PDF) | Tafasitamab-cxix (Monjuvi) | 12/1/20 |
CP.PHAR.409 (PDF) | Talazoparib (Talzenna) | 11/27/18 |
CP.PHAR.157 (PDF) | Taliglucerase Alfa (Elelyso) | 2/1/16 |
CP.PHAR.542 (PDF) | Talimogene laherepvec (Imlygic) | 9/1/21 |
CP.PMN.283 (PDF) | Tapinarof (Vtama) | 12/1/22 |
CP.PMN.104 (PDF) | Tasimelteon (Hetlioz, Hetlioz LQ) | 2/1/17 |
CP.PMN.105 (PDF) | Tavaborole (Kerydin) | 3/1/18 |
CP.PMN.244 (PDF) | Tazarotene (Arazlo, Fabior, Tazorac) | 9/1/20 |
CP.PHAR.452 (PDF) | Tazemetostat (Tazverik) | 3/1/20 |
CP.PHAR.575 (PDF) | Tebentafusp-tebn (Kimmtrak) | 6/1/22 |
CP.PMN.62 (PDF) | Tedizolid (Sivextro) | 3/1/15 |
CP.PHAR.114 (PDF) | Teduglutide (Gattex) | 5/1/13 |
CP.PMN.206 (PDF) | Tegaserod (Zelnorm) | 9/1/19 |
CP.PHAR.337 (PDF) | Telotristat Ethyl (Xermelo) | 6/1/17 |
CP.PHAR.77 (PDF) | Temozolomide (Temodar) | 9/1/11 |
CP.PHAR.324 (PDF) | Temsirolimus (Torisel) | 3/1/17 |
CP.PMN.224 (PDF) | Tenapanor (Ibsrela) | 3/1/20 |
CP.PMN.268 (PDF) | Tenofovir Alafenamide Fumarate (Vemlidy) | 12/1/21 |
CP.PHAR.492 (PDF) | Teplizumab (PRV-031) | 9/1/20 |
CP.PHAR.530 (PDF) | Tepotinib (Tepmetko) | 6/1/21 |
CP.PHAR.465 (PDF) | Teprotumumab (Tepezza) | 1/21/20 |
CP.PHAR.262 (PDF) | Teriflunomide (Aubagio) | 8/1/16 |
CP.PHAR.188 (PDF) | Teriparatide (Forteo) | 11/15/17 |
CP.PHAR.109 (PDF) | Tesamorelin (Egrifta SV) | 3/1/14 |
CP.PHAR.354 (PDF) | Testosterone (Testopel, Jatenzo, Kyzatrex, Tlando) | 8/1/17 |
CP.PHAR.92 (PDF) | Tetrabenazine (Xenazine) | 12/1/11 |
CP.PHAR.377 (PDF) | Tezacaftor/Ivacaftor; Ivacaftor (Symdeko) | 4/3/18 |
CP.PHAR.576 (PDF) | Tezepelumab-ekko (Tezspire) | 6/1/22 |
CP.PHAR.78 (PDF) | Thalidomide (Thalomid) | 9/1/11 |
CP.PHAR.437 (PDF) | Thioguanine (Tabloid) | 12/1/19 |
CP.PHAR.95 (PDF) | Thyrotropin Alfa (Thyrogen) | 3/1/12 |
CP.PHAR.386 (PDF) | Tildrakizumab-asmn (Ilumya) | 5/1/18 |
CP.PMN.84 (PDF) | Timothy Grass Pollen Allergen Extract (Grastek) | 8/31/17 |
CP.PHAR.361 (PDF) | Tisagenlecleucel (Kymriah) | 9/26/17 |
CP.PHAR.561 (PDF) | Tisotumab Vedotin-tftv (Tivdak) | 12/1/21 |
CP.PHAR.538 (PDF) | Tivozanib (Fotivda) | 6/1/21 |
CP.PHAR.211 (PDF) | Tobramycin (Bethkis, Kitabis Pak, TOBI, TOBI Podhaler) | 5/1/16 |
CP.PHAR.263 (PDF) | Tocilizumab (Actemra) | 7/1/16 |
CP.PHAR.267 (PDF) | Tofacitinib (Xeljanz, Xeljanz XR) | 1/30/18 |
CP.PHAR.591 (PDF) | Tofersen (BIIB067) | 12/1/22 |
CP.PHAR.27 (PDF) | Tolvaptan (Jynarque, Samsca) | 6/5/18 |
CP.PMN.107 (PDF) | Topical Immunomodulators | 9/1/06 |
CP.PMN.281 (PDF) | Topiramate Extended-Release (Qudexy XR, Trokendi XR) | 9/1/22 |
CP.PHAR.64 (PDF) | Topotecan (Hycamtin) | 6/1/11 |
CP.PMN.126 (PDF) | Toremifene (Fareston) | 4/1/10 |
CP.PHAR.204 (PDF) | Trabectedin (Yondelis) | 5/1/16 |
CP.PHAR.577 (PDF) | Tralokinumab-ldrm (Adbry) | 6/1/22 |
CP.PHAR.240 (PDF) | Trametinib (Mekinist) | 7/1/16 |
CP.PHAR.228 (PDF) | Trastuzumab/Biosimilars, Trastuzumab-Hyaluronidase | 6/1/16 |
CP.PHAR.199 (PDF) | Treprostinil (Orenitram, Remodulin, Tyvaso, Tyvaso DPI) | 3/1/16 |
CP.PHAR.371 (PDF) | Triamcinolone ER Injection (Zilretta) | 3/1/18 |
CP.PMN.207 (PDF) | Triclabendazole (Egaten) | 9/1/19 |
CP.PHAR.438 (PDF) | Trientine (Cuvrior, Syprine) | 12/1/19 |
CP.PMN.225 (PDF) | Trifarotene (Aklief) | 3/1/20 |
CP.PHAR.383 (PDF) | Trifluridine/Tipiracil (Lonsurf) | 11/16/16 |
CP.PHAR.509 (PDF) | Triheptanoin (Dojolvi) | 12/1/20 |
CP.PHAR.175 (PDF) | Triptorelin Pamoate (Trelstar, Triptodur) | 11/9/17 |
CP.PHAR.600 (PDF) | Trofinetide (NNZ-2566) | 12/1/22 |
CP.PHAR.497 (PDF) | Tucatinib (Tukysa) | 9/1/20 |
CP.PHAR.476 (PDF) | Ubrogepant (Ubrelvy) | 6/1/20 |
CP.PHAR.557 (PDF) | Udenafil | 12/1/21 |
CP.PMN.277 (PDF) | Ulcer Therapy Combinations | 6/1/22 |
CP.PHAR.531 (PDF) | Umbralisib (Ukoniq) | 6/1/21 |
CP.PHAR.443 (PDF) | Upadacitinib (Rinvoq) | 12/1/19 |
CP.PHAR.264 (PDF) | Ustekinumab (Stelara) | 8/1/16 |
CP.PHAR.466 (PDF) | Valoctocogene Roxaparvovec | 3/1/20 |
CP.PHAR.439 (PDF) | Valrubicin (Valstar) | 12/1/19 |
CP.PHAR.80 (PDF) | Vandetanib (Caprelsa) | 10/1/11 |
CP.PMN.273 (PDF) | Varenicline (Tyrvaya) | 3/1/22 |
CP.PHAR.265 (PDF) | Vedolizumab (Entyvio) | 7/1/16 |
CP.PHAR.163 (PDF) | Velaglucerase Alfa (VPRIV) | 2/1/16 |
CP.PHAR.601 (PDF) | Velmanase Alfa (Lamazym, Lamzede) | 12/1/22 |
CP.PHAR.91 (PDF) | Vemurafenib (Zelboraf) | 11/1/11 |
CP.PHAR.129 (PDF) | Venetoclax (Venclexta) | 9/1/18 |
CP.PHAR.187 (PDF) | Verteporfin (Visudyne) | 3/1/16 |
CP.PHAR.374 (PDF) | Vestronidase Alfa-vjbk (Mepsevii) | 1/19/18 |
CP.PHAR.169 (PDF) | Vigabatrin (Sabril) | 2/1/16 |
CP.PMN.145 (PDF) | Vilazodone (Viibryd) | 8/1/12 |
CP.PHAR.484 (PDF) | Viltolarsen (Viltepso) | 8/12/20 |
CP.PHAR.315 (PDF) | Vincristine Sulfate Liposome Injection (Marqibo) | 2/1/17 |
CP.PHAR.273 (PDF) | Vismodegib (Erivedge) | 8/1/16 |
CP.PHAR.504 (PDF) | Voclosporin (Lupkynis) | 9/1/20 |
CP.PHAR.372 (PDF) | Voretigene Neparvovec-rzyl (Luxturna) | 3/1/18 |
CP.PHAR.83 (PDF) | Vorinostat (Zolinza) | 12/1/12 |
CP.PHAR.525 (PDF) | Vosoritide (Voxzogo) | 3/1/21 |
CP.PHAR.451 (PDF) | Voxelotor (Oxbryta) | 3/1/20 |
CP.PHAR.550 (PDF) | Vutrisiran (Amvuttra) | 12/1/21 |
CP.PHAR.467 (PDF) | Zanubrutinib (Brukinsa) | 3/1/20 |
CP.PHAR.325 (PDF) | Ziv-aflibercept (Zaltrap) | 3/1/17 |
CP.PHAR.59 (PDF) | Zoledronic Acid (Reclast, Zometa) | 3/1/11 |
CP.PMN.172 (PDF) | Zolpidem Tartrate (Edluar, Intermezzo, Zolpimist) | 12/1/18 |
Payment Policies
Health care claims payment policies are guidelines used to assist in administering payment rules based on generally accepted principles of correct coding. They are used to help identify whether health care services are correctly coded for reimbursement. Each payment rule is sourced by a generally accepted coding principle. They include, but are not limited to claims processing guidelines referenced by the Centers for Medicare and Medicaid Services (CMS), Publication 100-04, Claims Processing Manual for physicians/non-physician practitioners, the CMS National Correct Coding Initiative policy manual (procedure-to-procedure coding combination edits and medically unlikely edits), Current Procedural Technology guidance published by the American Medical Association (AMA) for reporting medical procedures and services, health plan clinical policies based on the appropriateness of health care and medical necessity, and at times state-specific claims reimbursement guidance.
All policies found in the Western Sky Community Care Payment Policy Manual apply with respect to Western Sky Community Care members. Policies in the Western Sky Community Care Payment Policy Manual may have either a Western Sky Community Care or a “Centene” heading. In addition, Western Sky Community Care may from time to time employ a vendor that applies payment policies to specific services; in such circumstances, the vendor’s guidelines may also be used to determine whether a service has been correctly coded. Other policies (e.g., clinical policies) or contract terms may further determine whether a technology, procedure or treatment that is not addressed in the Payment Policy Manual is payable by Western Sky Community Care.
If you have any questions regarding these policies, please contact Member Services and ask to be directed to the Medical Management department.